Taking position: Effect of SGLT2i on arterial pressure, vascular damage, kidney disease and associated cardiovascular risk

被引：0

作者：

Inserra, Felipe ^{[1
,2
,3
,4
]}

Forte, Ezequiel ^{[5
]}

Elbert, Alicia ^{[6
]}

Waisman, Gabriel ^{[1
]}

Castellaro, Carlos ^{[3
]}

Buso, Carlos ^{[5
]}

Fairman, Enrique ^{[5
]}

Cobo, Augusto Lavalle ^{[5
]}

Manucha, Walter ^{[5
]}

Salmeri, Emiliano ^{[5
]}

Sanabria, Hugo ^{[5
]}

Sanchez, Ramiro ^{[5
]}

Terns, Paula Perez ^{[5
]}

Aranguren, Florencia ^{[6
]}

Arias, Pablo ^{[6
]}

Castano, Yanina ^{[6
]}

De Marziani, Guillermo ^{[6
]}

Faingold, Cristina ^{[6
]}

Gonzalez, Joaquin ^{[6
]}

Jawerbaum, Alicia ^{[6
]}

Vazquez, Fabiana ^{[6
]}

Wappner, Diego ^{[6
]}

Zaidel, Ezequiel J. ^{[6
]}

Aiello, Ernesto A. ^{[1
]}

Alfie, Jose ^{[1
]}

De Cerchio, Alejandro ^{[1
]}

Choi, Marcelo ^{[1
]}

Marquez, Diego ^{[1
]}

Piskorz, Daniel ^{[1
]}

Pupi, Luis Maria ^{[1
]}

Renna, Nicolas ^{[1
]}

Salazar, Martin ^{[1
]}

Dorado, Enrique ^{[3
]}

Ferder, Leon ^{[3
]}

Lavenia, Gustavo ^{[3
]}

Orias, Marcelo ^{[3
]}

Paganti, Luciana Gonzalez ^{[3
]}

Rigo, Diego H. ^{[3
]}

Diez, Guillermo Rosa ^{[3
]}

Sivak, Leonardo ^{[3
]}

Trimarchi, Hernan ^{[3
]}

Majul, Claudio ^{[5
]}

Sinay, Isaac ^{[5
]}

Marin, Marcos ^{[5
]}

Bonanno, Carlos ^{[5
]}

机构：

[1] Soc Argentina Hipertens Arterial, Buenos Aires, Argentina

[2] Com Salud Renal & Hipertens Arterial & Dano Vasc, Buenos Aires, Argentina

[3] Soc Argentina Nefrol, Buenos Aires, Argentina

[4] Univ Austral, Mecan Vasc Hipertens Arterial, Buenos Aires, Argentina

[5] Soc Argentina Cardiol, Buenos Aires, Argentina

[6] Soc Argentina Diabet, Buenos Aires, Argentina

来源：

REVISTA DE NEFROLOGIA DIALISIS Y TRASPLANTE | 2024年 / 44卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：49 / 51

页数：3

共 50 条

[31] SGLT2i vs bolus insulin as add-on to stable basal insulin treatment in type 2 diabetes and risk of cardiovascular disease and mortality: a nationwide observational study
Eriksson, J. W.
Bodegard, J.
Norhammar, A.
Thuresson, M.
Nathanson, D.
Nystrom, T.
DIABETOLOGIA, 2018, 61 : S58 - S59
[32] Predictors of Selection of a GLP1RA vs. SGLT2i in People with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
Agarwal, Shubham
Basit, Mujeeb A.
Bowen, Michael E.
Heitjan, Daniel
Mai, Christine
Marble, Kelsea
Xiang, Zichang
Lingvay, Ildiko
DIABETES, 2024, 73
[33] ADHERENCE OF CHRONIC KIDNEY DISEASE PATIENTS TO SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR (SGLT2I) DURING RAMADAN PERIOD
Lee, Fei Yee
Tiong, Kung Ung
Rosdi, Hajar Ahmad
Liew, Hui Nee
Kwong, Gabriel Kin Wei
Ismail, Siti Hafizah Mohammad
Yakob, Suryati
NEPHROLOGY, 2024, 29 : 91 - 91
[34] Arterial stiffness, ambulatory blood pressure monitoring and their association with cardiovascular risk in patients with chronic kidney disease and arterial hypertension
Semenov, V. V.
MEDICAL PERSPECTIVES-MEDICNI PERSPEKTIVI, 2018, 23 (03): : 181 - 188
[35] Initiation of SGLT2i vs. GLP1-RA and the Risk of Acute Kidney Injury in Persons with Type 2 Diabetes Mellitus
Heide-Jorgensen, Uffe
Jensen, Simon K.
Andersen, Ina T.
Thomsen, Reimar W. W.
Christiansen, Christian Fynbo
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 362 - 363
[36] Recent trends in GLP-1 RA and SGLT2i use among people with type 2 diabetes and atherosclerotic cardiovascular disease in the USA
King, Aaron
Tan, Xi
Dhopeshwarkar, Neil
Bohn, Rhonda
Dea, Katherine
Leonard, Charles E.
de Havenon, Adam
BMJ OPEN DIABETES RESEARCH & CARE, 2024, 12 (05)
[37] Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4
Weber, Chek Ing Kiu
Duchateau-Nguyen, Guillemette
Solier, Corinne
Schell-Steven, Annette
Hermosilla, Ricardo
Nogoceke, Everson
Block, Geoffrey
CLINICAL KIDNEY JOURNAL, 2014, 7 (02): : 167 - 173
[38] The effect of SGLT2i on in-hospital acute heart failure risk in acute myocardial infarction patients-a retrospective study
Zhu, Yi
Zhang, Jia-li
Jin, Hong
Ji, Yuan
Wang, Fang-fang
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
[39] SODIUM GLUCOSE COTRANSPORTER-2 SELECTIVE INHIBITORS (SGLT2I) FOR RETARDING DIABETIC KIDNEY DISEASE PROGRESSION: A SYSTEMATIC REVIEW AND META-ANALYSIS
Bolignano, Davide
Coppolino, Giuseppe
Pisano, Anna
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
[40] SGLT2i as fourth-line therapy and risk of mortality, end-stage renal diseases and cardiovascular diseases in patients with type 2 diabetes mellitus
Wong, C. K. H.
Tang, E. H. M.
Man, K. K. C.
Chan, E. W. Y.
Wong, I. C. K.
Lam, C. L. K.
DIABETES & METABOLISM, 2021, 47 (04)

← 1 2 3 4 5 →